Antimicrobials are a broad range of medicines used to prevent and treat infections in humans, animals, and plants, including antibiotics, antivirals, antifungals and antiparasitics. The discovery of penicillin in 1928 by Alexander Flemming has been widely recognized as one of the greatest scientific advancements of the 20th century, but what happens when there are no new antimicrobials being discovered and the ones we have available no longer work? In this episode of the Public Health Insight Podcast, Mr. Oliver Schact, CEO of OpGen, joins to talk about:The drivers of antimicrobial resistance (AMR); The impact of COVID-19 and lessons learned; and How precision medicine can help to combat infectious diseases and the emergence of AMR. Podcast GuestsOliver SchachtPodcast HostsWilliam Wang, BA, MPHGordon Thane, BMSc, MPH, PMP®References for Our Discussion World Economic Forum: The looming health catastrophe that could be more deadly than COVID-19World Health Organization: Antimicrobial resistanceSubscribe to the NewsletterWhat if there was an easy way to receive timely information about public health and global health right to your inbox? Subscribe to the newsletter to stay in the loop about the latest news, live events, jobs, and professional development opportunities. Subscribe to ensure you don’t miss out: https://thepublichealthinsight.com/subscribe/. Tell A FriendIf you enjoy our podcasts, it would mean the world if you shared it on social media and tagged us. If you are not the social media type, we would appreciate it if you shared it with a friend or colleague who you think might enjoy the podcast. It helps us to get discovered by other people.